为丰富和发展表面活性剂减阻体系,研究了阳离子Gemini表面活性剂丙撑基双(十八烷基二甲基氯化铵)(18-3-18)与水杨酸钠(NaSal)组成的新型胶束体系的流变和减阻性能。考察了不同浓度胶束体系的流变特性,讨论了该胶束体系的摩擦阻力系数和...为丰富和发展表面活性剂减阻体系,研究了阳离子Gemini表面活性剂丙撑基双(十八烷基二甲基氯化铵)(18-3-18)与水杨酸钠(NaSal)组成的新型胶束体系的流变和减阻性能。考察了不同浓度胶束体系的流变特性,讨论了该胶束体系的摩擦阻力系数和减阻率随广义雷诺数的变化关系,并比较了在光滑管及粗糙管中该体系的减阻效果。结果表明,18-3-18/NaSal胶束体系具有良好的黏弹性、触变性和剪切变稀性。随胶束体系浓度增大,减阻效果提高。对18-3-18/NaSal(5 mmol L 1/10 mmol L 1)胶束减阻体系,存在临界广义雷诺数,最大减阻率为78.5%;对18-3-18/NaSal(7.5mmol L 1/15 mmol L 1,10 mmol L 1/20 mmol L 1)胶束体系在光滑管中的最大减阻率可分别达到82.3%和81.7%。该胶束体系在光滑管中的减阻效果优于粗糙管中的减阻效果,表明18-3-18/NaSal胶束是一种新型减阻胶束体系。展开更多
BACKGROUND: It has been reported that high-dose salicylates improve free fatty acids (FFAs)-induced insulin resistance and beta-cell dysfunction in vitro, but the mechanism remains uncertain. In insulin-resistant rats...BACKGROUND: It has been reported that high-dose salicylates improve free fatty acids (FFAs)-induced insulin resistance and beta-cell dysfunction in vitro, but the mechanism remains uncertain. In insulin-resistant rats, we found that the supplementation of sodium salicylate is associated with a reduction of plasma malondialdehyde (MDA), a marker of oxidative stress. Few studies have investigated the effects of salicylates on oxidative stress levels in insulin-resistant animal models. This study aimed to assess the effect of sodium salicylate on insulin sensitivity and to explore the potential mechanism by which it improves hepatic and peripheral insulin resistance. METHODS: Intralipid+heparin (IH), saline (SAL), or intralipid+heparin+sodium salicylate (IHS) were separately infused for 7 hours in normal Wistar rats. During the last 2 hours of the infusion, hyperinsulinemic-euglycemic clamping was 3 performed with [6-(3)H] glucose tracer. Plasma glucose was measured using the glucose oxygenase method. Plasma insulin and C-peptide were determined by radioimmunoassay. MDA levels and glutathione peroxidase (GSH-PX) activity in the liver and skeletal muscle were measured with colorimetric kits. RESULTS: Compared with infusion of SAL, IH infusion increased hepatic glucose production (HGP), and decreased glucose utilization (GU) (P<0.05). The elevation of plasma free fatty acids increased the MDA levels and decreased the GSH-PX activity in the liver and muscle (P<0.01). Sodium salicylate treatment decreased HGP, elevated GU (P<0.05), reduced MDA content by 60% (P<0.01), and increased the GSH-PX activity by 35% (P<0.05). CONCLUSIONS: Short-term elevation of fatty acids induces insulin resistance by enhancing oxidative stress levels in the liver and muscle. The administration of the anti-inflammatory drug sodium salicylate reduces the degree of oxidative stress, therefore improving hepatic and peripheral insulin resistance. IKK-beta and NF-kappa B provide potential pathogenic links to oxidative stress.展开更多
文摘为丰富和发展表面活性剂减阻体系,研究了阳离子Gemini表面活性剂丙撑基双(十八烷基二甲基氯化铵)(18-3-18)与水杨酸钠(NaSal)组成的新型胶束体系的流变和减阻性能。考察了不同浓度胶束体系的流变特性,讨论了该胶束体系的摩擦阻力系数和减阻率随广义雷诺数的变化关系,并比较了在光滑管及粗糙管中该体系的减阻效果。结果表明,18-3-18/NaSal胶束体系具有良好的黏弹性、触变性和剪切变稀性。随胶束体系浓度增大,减阻效果提高。对18-3-18/NaSal(5 mmol L 1/10 mmol L 1)胶束减阻体系,存在临界广义雷诺数,最大减阻率为78.5%;对18-3-18/NaSal(7.5mmol L 1/15 mmol L 1,10 mmol L 1/20 mmol L 1)胶束体系在光滑管中的最大减阻率可分别达到82.3%和81.7%。该胶束体系在光滑管中的减阻效果优于粗糙管中的减阻效果,表明18-3-18/NaSal胶束是一种新型减阻胶束体系。
基金supported by a grant from the Bureau of Education of Liaoning Province,China (No.20060999)
文摘BACKGROUND: It has been reported that high-dose salicylates improve free fatty acids (FFAs)-induced insulin resistance and beta-cell dysfunction in vitro, but the mechanism remains uncertain. In insulin-resistant rats, we found that the supplementation of sodium salicylate is associated with a reduction of plasma malondialdehyde (MDA), a marker of oxidative stress. Few studies have investigated the effects of salicylates on oxidative stress levels in insulin-resistant animal models. This study aimed to assess the effect of sodium salicylate on insulin sensitivity and to explore the potential mechanism by which it improves hepatic and peripheral insulin resistance. METHODS: Intralipid+heparin (IH), saline (SAL), or intralipid+heparin+sodium salicylate (IHS) were separately infused for 7 hours in normal Wistar rats. During the last 2 hours of the infusion, hyperinsulinemic-euglycemic clamping was 3 performed with [6-(3)H] glucose tracer. Plasma glucose was measured using the glucose oxygenase method. Plasma insulin and C-peptide were determined by radioimmunoassay. MDA levels and glutathione peroxidase (GSH-PX) activity in the liver and skeletal muscle were measured with colorimetric kits. RESULTS: Compared with infusion of SAL, IH infusion increased hepatic glucose production (HGP), and decreased glucose utilization (GU) (P<0.05). The elevation of plasma free fatty acids increased the MDA levels and decreased the GSH-PX activity in the liver and muscle (P<0.01). Sodium salicylate treatment decreased HGP, elevated GU (P<0.05), reduced MDA content by 60% (P<0.01), and increased the GSH-PX activity by 35% (P<0.05). CONCLUSIONS: Short-term elevation of fatty acids induces insulin resistance by enhancing oxidative stress levels in the liver and muscle. The administration of the anti-inflammatory drug sodium salicylate reduces the degree of oxidative stress, therefore improving hepatic and peripheral insulin resistance. IKK-beta and NF-kappa B provide potential pathogenic links to oxidative stress.
